Drug Development/R&D- OHE

Insight
May 2021

Would Waiving COVID-19 Vaccines Patents Save Lives?

Insight
March 2021

Does Government Funding Increase Public Sector Development of New Medicines?

News
June 2020

OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare

Past Event
April 2020

How Should the World Pay for a COVID-19 Vaccine?

News
April 2020

Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine

News
March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

News
March 2020

Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds

News
February 2020

A Final MVAC Blueprint—and the Start of an R&D Revolution?

News
September 2019

Data Governance Arrangements for Real-world Evidence in Japan

Insight
May 2019

We Asked, You Answered: Reflections on the First Round of MVAC Feedback

News
March 2019

The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback

Latest Research & Publications

Individual, Health System, and Societal Impacts of Anti-seizure Medicine Use During Pregnancy

The Dynamics of Drug Shortages

2022 OHE Annual Report to the Charity Commission

Capturing the Broader Value of Antibiotics

Innovation for Health System Efficiency and Improvement

Proposals for a Novel UK Antimicrobial Subscription Model: How Will Antibiotic Innovation be Scored?

Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective

Reimagining Prevention for a Healthier, More Prosperous Society

All Publications

Drug Development Process and R&D

Filter results by

Drug Shortages: What are the causes, consequences and pathways to a solution?

Drug shortages are on the rise – but what is their impact?

Filter results by

Would Waiving COVID-19 Vaccines Patents Save Lives?

Does Government Funding Increase Public Sector Development of New Medicines?

Payment Models for Multi-Indication Therapies

OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare

How Should the World Pay for a COVID-19 Vaccine?

Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds

A Final MVAC Blueprint—and the Start of an R&D Revolution?

Data Governance Arrangements for Real-world Evidence in Japan

We Asked, You Answered: Reflections on the First Round of MVAC Feedback

The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback

Share on Mastodon